Eye movement abnormalities in GBA1-related Parkinson’s disease and non-manifesting GBA1-carriers
Objective: To perform an in-depth characterization of eye movement abnormalities in Parkinson’s disease (PD) and non-manifesting carriers of GBA1 pathogenic variants. Background: Eye movement abnormalities…Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology in patients with IPDWD correlates with visuospatial and/or visuoconstructive alterations Background: Visuospatial functioning and/or visuoconstructive skills are a cognitive…Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice
Objective: To test whether the patient-derived MDS-UPDRS Parts assessing non-motor (Part 1) and motor (Part 2) functional impact of PD can be summed to render…Mortality Rate, Cause of Death and Factors Associated with Mortality in Late Stage Parkinson’s Disease
Objective: The aim was to carry out a long-term follow-up of a cohort of patients in late stage Parkinson’s disease (PD) with focus on mortality…Increasing diagnostic accuracy of Multiple System Atrophy – A Videolibrary on clinical and imaging features
Objective: To provide short, high-quality videos and MRI images presenting typical MSA features to supplement new MDS-MSA criteria1. Background: The MDS criteria for the diagnosis…Palliative Care in Advanced Parkinson’s Disease: Descriptive Analysis and Symptom Impact
Objective: These preliminary study aims to describe the primary clinical features of Parkinson's disease patients requiring palliative care, as assessed by the Edmonton Symptom Assessment…Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies
Objective: We aimed to develop a clinical scale that distinguishes between Multiple System Atrophy (MSA) and 4-repeat tauopathies (4RT: CBD, PSP) using a standardized neurological…Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg
Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…Attention/Working memory and Executive Tests in Parkinson’s disease: Review, Critique and Recommendations
Objective: To evaluate the clinimetric properties of the Attention/Working memory and Executive domain tests used in Parkinson’s disease (PD) on behalf of the Movement Disorder…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 35
- Next Page »